Journal
LEUKEMIA RESEARCH
Volume 36, Issue 10, Pages 1290-1295Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2012.05.023
Keywords
MDS; Methylation; Wnt pathway; Wnt antagonists; beta-Catenin; Azacitidine
Categories
Funding
- Regione Toscana, Bando Salute
- Ente Cassa di Risparmio di Firenze (ECR)
- Ministero per l'Istruzione, l'Universita e la Ricerca (MIUR)
Ask authors/readers for more resources
We observed aberrant gene methylation of Wnt antagonists: sFRP1, sFRP2, sFRP4, sFRP5 and DKK1 in marrow cells of 55 MDS cases. Methylation of Wnt antagonist genes was associated with activation of the Wnt signaling pathway, consistent with the up-regulation of the Wnt downstream genes TCF1 and LEF1. Azacitidine exposure induced demethylation of Wnt-antagonist gene promoters and reduction of the non-phosphorylated beta-catenin (NPBC) which is prevalent during Wnt pathway inactivation. Presence of >= 5% of bone marrow blasts was associated with methylation of sFRP1 and DKK1 and with methylation of more than two of the five Wnt antagonist genes. (C) 2012 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available